Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Las Vegas Sands Corp. (LVS) Is Positioned to Rise Over This Stock

Page 1 of 2

A key concern for many casino investors is slowing growth in Macau. However, this has proven to be a lot less of an issue than what the market originally expected. The subsequent market correction has sent casino shares soaring by the double-digits. New issues, however, have arisen for MGM that can ultimately bring similar returns if resolved in an appropriate manner. Below, I present my take on LVS and MGM.

Las Vegas Sands Corp. (NYSE:LVS)Las Vegas Sands Corp. (NYSE:LVS): Risky but Full of Growth

Las Vegas Sands has now risen around 70% from the 52-week low–largely driven by Macau experiencing less deceleration than expected. In 3Q12, Macau gambling revenue rose 7.9% y-o-y as a result of greater popularity among the middle-class demographic. In fact, Macau’s third quarter 2012 gambling revenue went up by 19.3%, which actually marked acceleration. And even though the company’s fourth quarter EPS of $0.54 missed consensus by 5 cents, revenue was in-line, and the stock price still jumped 4.2% after hours.

The gaming win share was 20%+ in the month of October. Table revenue performance in Macau expanded by 26% y-o-y, and winnings per mass table rose to $8,700. The only real negative is that, in the fourth quarter, margins fell from a $240 million tax loss on the Marina Bay Sands. And now reports are coming out that Macau resorts are selling out ahead of the Chinese New Year, and Capital Securities is now saying that LVS will see its biggest surge from expansing to 40% of all rooms in the booming region. So much for those Macau concerns.

At the same time, the company has been aggressive in growth. After April 2012, the company added two casinos and over 3,600 hotel rooms. The Parisian Macau Building project is also waiting for the local government’s green light to proceed, but the plan is to open before 2016. Management is also only shooting for projects that can deliver ROIs north of 20%. Sheldon Adelson, the company’s billionaire CEO, is also the company’s largest shareholder, so he has a vested interest in constructive, value-creating growth.

MGM Resorts International (NYSE:MGM): A Downside Story but With Turnaround Potential

In contrast to LVS, MGM faces a “downside story.” For some time, I have characterized MGM as the “danger” pick of the casino operators. While it generates an incredible free cash flow yield of 10.2%, it is still in the red and lost $1.34 per share over the trailing twelve months. It is expected to lose $0.35 per share more next year. Perhaps most pressing, net debt stands at $11.3 billion, which eclipses the $6.3 billion market cap. It is for these reasons that Deutsche Bank recently downgraded the stock to a “hold.”

The company is also a defendant in a widely-covered lawsuit. The plaintiff, MGT Capital Investments Inc. (NYSEAMEX:MGT), has gone through considerable restructuring, cost-cutting, and management turnover to get to where it is today. This messy process has, in turn, substantially discounted the stock, which now has a compelling value story that consists of monetizing patents. In mid-2012, the company acquired patent rights to a gaming system that to, put it briefly, consists of linking two gaming machines together to a bonus game that, when triggered, allows the players to compete against one another.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!